Skip to content

CRYOSTORAGE

Active
Public limited companyfounded 200818 yrs activeEsplanade Oscar Van de Voorde 1, 9000 Gent, BelgiumKBO/BCE: BE 0899.649.957
Summary

CRYOSTORAGE has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-120k) and a net result of €-26k. Equity is shrinking by ~13.6% per year across the filed fiscal years. Its solvency ranks better than 5% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
42 / 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability21▼-5
Solvency0▼-1
Growth32=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.11 against 0.12 in 2024; short-term debt: 130.2% and cash: 14.6% of total assets), and equity is negative.
Credit check for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-30.2%
Return on assets
-6.6%
Age of the figures
15 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 18 years 0 20 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year €-120k
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 29-01-2026, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
2 d early
2024
25 d early
2023
on the day
2022
on the day
2021
on the day
2020
34 d early
2019
1 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close24-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€-120k▼ 28.1%
2024 · €-94k
2019: €-48k 2020: €-58k 2021: €-80k 2022: €-55k 2023: €-76k 2024: €-94k
2019 → 2025
Total assets
€399k▼ 0.1%
2024 · €399k
2019: €343k 2020: €347k 2021: €362k 2022: €401k 2023: €400k 2024: €399k
2019 → 2025
Net result
€-26k▼ 45.8%
2024 · €-18k
2019: €-17k 2020: €-10k 2021: €-22k 2022: €25k 2023: €-21k 2024: €-18k
2019 → 2025
Working capital
€-461k▼ 6.1%
2024 · €-435k
2019: €-388k 2020: €-399k 2021: €-421k 2022: €-396k 2023: €-417k 2024: €-435k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€-80k-€-55k▲ 31.3%€-76k▼ 38.4%€-94k▼ 23.8%€-120k▼ 28.1%
Operating result€-5k-€39k€-655€-589▲ 10.1%€-597▼ 1.4%
Net result€-22k-€25k€-21k€-18k▲ 14.1%€-26k▼ 45.8%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€-40k€-20k€0€20k€40kOperating result 2021: €-5k€-5kNet result 2021: €-22k€-22kOperating result 2022: €39k€39kNet result 2022: €25k€25kOperating result 2023: €-655€-655Net result 2023: €-21k€-21kOperating result 2024: €-589€-589Net result 2024: €-18k€-18kOperating result 2025: €-597€-597Net result 2025: €-26k€-26k20212022202320242025€-30k€-20k€-10k€0Operating result 2023: €-655€-655Net result 2023: €-21k€-21kOperating result 2024: €-589€-589Net result 2024: €-18k€-18kOperating result 2025: €-597€-597Net result 2025: €-26k€-26k202320242025
The operating result stays negative: a loss of €597 in 2025 against €589 in 2024; the loss grows.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €399k
Fixed assets €341k =
Current assets €58k ▼ 1.0%
Key figures and ratios
2025 value · change against 2024
Solvency
-30.2%
2024 · -23.5%
Current ratio
0.11
2024 · 0.12
Debt to equity
-4.31
2024 · -5.25
ROA
-6.6%
2024 · -4.5%
Debt
€519k
2024 · €493k
Debt ≤ 1 year
€519k
2024 · €493k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 31 lines
Balance sheet Code20242025
Assets
Total assets20/58€399k€399k
Fixed assets21/28€341k€341k=
Intangible fixed assets21€341k€341k=
Tangible fixed assets22/27€0€0=
Furniture and vehicles24€0€0=
Current assets29/58€59k€58k
Amounts receivable within one year40/41€3€3=
Other amounts receivable41€3€3=
Cash at bank and in hand54/58€59k€58k
Equity and liabilities
Total equity and liabilities10/49€399k€399k
Equity10/15€-94k€-120k
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€110€110=
Non-distributable reserves130/1€110€110=
Legal reserve130€110€110=
Profit (loss) carried forward14€-156k€-183k
Amounts payable17/49€493k€519k
Amounts payable within one year42/48€493k€519k
Other amounts payable47/48€493k€519k
Income statement Code20242025
Other operating charges640/8€141€144
Gross operating margin9900€-448€-453
Operating profit (loss)9901€-589€-597
Financial charges65/66B€18k€26k
Recurring financial charges65€18k€26k
Profit (loss) for the period before taxes9903€-18k€-26k
Profit (loss) for the period9904€-18k€-26k
Profit (loss) for the period to be appropriated9905€-18k€-26k
Appropriation of the result
Profit (loss) to be appropriated9906€-156k€-183k
Profit (loss) brought forward from the previous period14P€-138k€-156k

The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
23-09
State Gazette act Merger · Shareholding
Merger · Shareholding · Legal form clause14 facts ▸
  • Merger, met fusie door overneming gelijkgestelde verrichting, hele vermogen van [B] overgaat op [A] door ontbinding zonder vereffening
  • Shareholding, 100
  • Other statement, economische verantwoording
  • Other statement, vereenvoudiging juridische en administratieve structuur
  • Other statement, zakelijke en economische overwegingen
  • Legal form clause, Cryostorage
  • Declaration, no special rights or other securities
  • Declaration, no special rights or other securities
  • Declaration, no special advantage to board members
  • Declaration, no special advantage to board members
  • Declaration, no real estate or real property rights
  • Statutes amendment
  • +2 further facts in this act
20-03
State Gazette act Resignations: MG Investment (director) and Robert Broothaerts (director)
Reappointment: MG Investment (director) · Permanent representative: Ignace De Paepe5 facts ▸
  • Board meeting, 01/12/2022
  • Director resignation, MG Investment (director)
  • Director resignation, Robert Broothaerts (director)
  • Director reappointment, MG Investment (director)
  • Permanent representative, Ignace De Paepe
29-01
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial Weakest financial yearnet €-26k
Net result drops to €-26k, the lowest in the series.
06-01
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-01
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-01
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial Back to profitnet €25k
Net result €25k after 3 loss-making years.
31-01
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2020
28-12
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
30-01
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
19-12
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2017
14-12
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
01-02
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 1 day late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 director, no change since 2026
MG Investment
Director · Legal entity · perm. rep.: Ignace De Paepe
Current
20-03-2026 MG Investment: Reappointed as Director
20-03-2026 Broothaerts Robert: Resigned as Director
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2008
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Esplanade Oscar Van de Voorde 19000 Gent
Ground area
1,701 m²
Building footprint
822 m²
Volume, LiDAR
526 m³
Parcel 44809I0649/52A002, Flanders · tallest building 4.8 m. Linked by address, not a title deed.
1 establishment unit
Esplanade Oscar Van de Voorde 1, 9000 Gent
Warehousing and storage
since 20082.173.637.366
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44809I0649/52A002 Flanders 1,701 m² 1 · 822 m² 4.8 m
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Articles of association

Purpose
Het testen, bewerken, bewaren en distribueren van menselijk lichaamsmateriaal, samples en andere materialen in een stofvrije, geklimatiseerde omgeving (biobank) die voorzien is van…
Full purpose (5 activities)
  1. Het testen, bewerken, bewaren en distribueren van menselijk lichaamsmateriaal, samples en andere materialen in een stofvrije, geklimatiseerde omgeving (biobank) die voorzien is van een kwaliteitssysteem en uitgerust is met alle nodige en voorgeschreven veiligheden om deze unieke en waardevolle materialen vierentwintig (24) uur per dag, zeven (7) dagen in de week geeontroleerd op te slaan.
  2. Het aankopen, verkopen, importeren, exporteren, plaatsen, inrichten, onderhouden en herstellen van systemen, toestellen en installaties voor bewaring in een koude - en/of wanne omgeving.
  3. De vennootschap mag alle technisehe ontwerpactivitciten uitvoeren, bouwen en assembleren van deze systcmen, toestellen en installaties evenals het plaatsen van alle somten elektronischc installaties.
  4. De vennootschap mag tevens verhuring en bet onderhoud doen, zowel voor eigen rekening als voor rekening van derden, zelfs als commissionair en tussenpersoon, in de meest ruime zin.
  5. Dit alles in de meest ruime zin. De vennootschap handelt voor eigen rekening, in consignatie, in commissie, als tussenpersoon of als vertegenwoordiger. Zij mag deelnemen in alle ondernemingen die ene gelijkaardig voorwerp nastreven, ook aanverwant, of die de verwezenlijking van het voorwerp vergemakkelijken. In de algemene regel mag de vennootschap alle daden stellen van burgerlijke, commerciële, roerende, onroerende, industriële of financiële aard, welke rechtstreeks of onrechtstreeks, geheel of gedeeltelijk in verband staan met het voorwerp.
Other provisions of the articles (2)
  • Other statement
  • Accounting effect: 01-07-2026

Structure & network

Acquisitions and mergers

1 transaction
Taken over by:NEVIMO NV
BE 0446.588.493operation treated as a merger by absorption · proposal · State Gazette act of 23-09-2026 (2 acts) · effective 14-09-2026

Capital and shareholders

Shareholders according to the acts
Stated in the act act of 23-09-2026 ↗
  • NEVIMO NV (BE 0446.588.493) all shares · 100%

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 698 companies in sector 86910 we hold annual accounts for 520. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded05-08-2008
Fiscal year end30-06
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
52100Warehousing and storage
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.